Scott Lim, DO
Dermatology · Erie, PANPI 1376517151
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 19.3%. Reporting peaked in 2023 at $7,539 and has fallen 77.5% since, to $1,698 in 2025. Among dermatology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 660 payments — averaging $39.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$5K
- Johnson & Johnson$2K
- AbbVie$1K
- Arcutis Biotherapeutics, Inc.$1K
- Novartis$1K
- plus $11K from 31 others
Across 5 payments — averaging $2596.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$10K
- Abbott$3K
What the payments were for
- Consulting fees$5,50021%
- Travel & lodging$4,22616%
- Food & beverage$15,40160%
- Education$6583%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 38 | $4,984 |
| Abbott | 5 | $4,689 |
| Johnson & Johnson(2 entities) | 117 | $1,938 |
| AbbVie | 57 | $1,248 |
| Arcutis Biotherapeutics, Inc. | 8 | $1,144 |
| Novartis | 44 | $1,118 |
| Journey Medical Corporation | 36 | $979 |
| Galderma Laboratories, L.p. | 32 | $884 |
| Pfizer | 34 | $860 |
| Sanofi | 26 | $823 |
| E.r. Squibb & Sons, L.L.C. | 26 | $718 |
| Incyte Corporation | 34 | $710 |
| Biosense Webster, Inc. | 4 | $699 |
| Regeneron Healthcare Solutions, Inc. | 23 | $690 |
| Sun Pharmaceutical Industries Inc. | 30 | $650 |
| Lilly USA, LLC | 21 | $550 |
| Amgen | 18 | $464 |
| Bristol Myers Squibb | 8 | $399 |
| UCB, Inc. | 14 | $362 |
| LEO Pharma Inc. | 15 | $291 |
| Janssen Scientific Affairs, LLC | 5 | $290 |
| Dermavant Sciences, Inc. | 15 | $270 |
| Mayne Pharma Commercial LLC | 17 | $220 |
| Boston Scientific | 1 | $137 |
| Si-bone, Inc. | 1 | $134 |
| Verrica Pharmaceuticals Inc. | 4 | $82 |
| Genentech USA, Inc. | 4 | $67 |
| W. L. Gore & Associates, Inc. | 1 | $64 |
| Almirall LLC | 4 | $62 |
| VYNE Pharmaceuticals Inc. | 3 | $50 |
| Boehringer Ingelheim | 2 | $49 |
| Organon | 2 | $45 |
| Biofrontera Inc. | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 1 | $28 |
| Prugen, Inc. Pharmaceuticals | 6 | $23 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| DUSA Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,785 in reported general payments places this provider in the 90th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $98,870 |
| Metronidazole | 48 | $3,834 |
| Clobetasol Propionate | 52 | $1,606 |
| Tacrolimus | 14 | $1,508 |
| Betamethasone Dipropionate | 36 | $1,498 |
| Dapsone | 17 | $1,463 |
| Mometasone Furoate | 63 | $1,249 |
| Doxycycline Hyclate | 28 | $867 |
| Ketoconazole | 37 | $812 |
| CiclopiroxCiclopirox Olamine | 46 | $785 |
| Clindamycin Phosphate | 16 | $749 |
| Hydrocortisone Valerate | 17 | $718 |
| Mycophenolate Mofetil | 19 | $620 |
| Hydrocortisone | 76 | $579 |
| ValacyclovirValacyclovir Hcl | 30 | $363 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Erie
- Scott GottliebExton$2.1M
- Douglas KressWexford$2M
- Stephen HessPhiladelphia$1.7M
- Adel HaqueYardley$1M
- Joel GelfandPhiladelphia$649K
- Neil NirenPittsburgh$574K
- Victoria WerthPhiladelphia$547K
- Mark SeralyMc Murray$545K
- Laura FerrisPittsburgh$502K
- Oleg AkilovPittsburgh$409K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.